GILEAD SCIENCES

Corporation with Board of Directors
Foster City, California, United States
Closing date: December 31
Date of the Last Annual General Meeting: May 12 2021
- S&P 100
- E&B Pharmaceuticals & Biotechnology
- Bloomberg - Gender Equality ,
- Science Based Targets (1.5°C)

Governance leadership structure

Board of Directors

Daniel O'DAY
Chair
Since about 3 years

Other directorships

9 voting members without any non-voting

Independents
Executives
Employees representatives
State representatives
Other

Directors
average seniority 4.1 years
4.2 years for elected by shareholders

Directors
average age 64.5 years
64.5 years for elected by shareholders

Chair and CEO roles are combined:
Is there a Lead Independent Director?	Yes
Are all of the Audit Committee members independent?	Yes
Majority of independent members in the Board?	Yes

9 members

Senior Management Board

Daniel O'DAY
Chief Executive Officer
Since about 3 years
Other directorships

85.4 % Percentage of variable remunerations in 2020 Global compensation

Board & Leadership

Board of Directors

Your Internet Explorer version is outdated. Upgrade it, or download Google Chrome for a better experience.